Cargando…
MxA mRNA Quantification and Disability Progression in Interferon Beta-Treated Multiple Sclerosis Patients
Even though anti-interferon beta (IFNβ) antibodies are the main determinants of IFNβ bioactivity loss and Myxovirus-resistance protein A (MxA) is the most established marker of IFNβ biological activity in IFNβ-treated multiple sclerosis patients, their usefulness in the routine clinical practice is...
Autores principales: | Serana, Federico, Imberti, Luisa, Amato, Maria Pia, Comi, Giancarlo, Gasperini, Claudio, Ghezzi, Angelo, Martinelli, Vittorio, Provinciali, Leandro, Rottoli, Maria Rosa, Sotgiu, Stefano, Stecchi, Sergio, Vecchio, Michele, Zaffaroni, Mauro, Cordioli, Cinzia, Capra, Ruggero |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986392/ https://www.ncbi.nlm.nih.gov/pubmed/24733382 http://dx.doi.org/10.1371/journal.pone.0094794 |
Ejemplares similares
-
Less Frequent and Less Severe Flu-Like Syndrome in Interferon Beta-1a Treated Multiple Sclerosis Patients with at Least One Allele Bearing the G>C Polymorphism at Position -174 of the IL-6 Promoter Gene
por: Bertoli, Diego, et al.
Publicado: (2015) -
Type I interferon-dependent gene MxA in perinatal HIV-infected patients under antiretroviral therapy as marker for therapy failure and blood plasmacytoid dendritic cells depletion
por: Badolato, Raffaele, et al.
Publicado: (2008) -
Detection of new biallelic polymorphisms in the human MxA gene
por: Duc, Tam Tran Thi, et al.
Publicado: (2012) -
MxA for differentiating viral and bacterial infections in adults: a prospective, exploratory study
por: Metz, Matthäus, et al.
Publicado: (2023) -
Vaccinia virus and Cowpox virus are not susceptible to the interferon-induced antiviral protein MxA
por: Lorenzo, María M., et al.
Publicado: (2017)